Health Care & Life Sciences » Biotechnology | ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc.
Stock Exchange Other OTC
EPS
$0.2
Market Cap
$337.37 M
Shares Outstanding
718.13 M
Public Float
-
ProMetic Life Sciences Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
718.13 M
Public Float
-
ProMetic Life Sciences Inc.
Stock Exchange Toronto Stock Exchange Prices
EPS
CAD262.7
Market Cap
CAD399.36 M
Shares Outstanding
23.22 B
Public Float
559.92 M

Profile

Address
440 Armand-Frappier Boulevard
Laval Québec H7V 4B4
Canada
Employees -
Website http://www.prometic.com
Updated 07/04/2019
Prometic Life Sciences, Inc. engages in the development of therapeutic products focusing on unmet medical needs in the field of fibrosis, autoimmune disease or inflammation, and cancer. It operates through the following segments: Bioseparations, Plasma-derived Therapeutics, and Small Molecule Therapeutics. The Bioseparations segment is involved in large-scale purification of biologics and the elimination of pathogens.

Financials

View All

Pierre Laurin
President, CEO & Non-Independent Director
Bruce J. Wendel
Non-Independent Director